2-[3-(3-methyl-2H-benzimidazol-1-yl)-5-phenylphenoxy]-9-[4-[2-(4-methylphenyl)-2-adamantyl]-2-pyridinyl]carbazole
C54H48N4O — CID 162696349
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[3-(3-methyl-2H-benzimidazol-1-yl)-5-phenylphenoxy]-9-[4-[2-(4-methylphenyl)-2-adamantyl]-2-pyridinyl]carbazole
2-[3-(3-methyl-2H-benzimidazol-1-yl)-5-phenylphenoxy]-9-[4-[2-(4-methylphenyl)-2-adamantyl]-2-pyridinyl]carbazole (PubChem CID 162696349) has the molecular formula C54H48N4O and a molecular weight of 769.00 g/mol. Its IUPAC name is 2-[3-(3-methyl-2H-benzimidazol-1-yl)-5-phenylphenoxy]-9-[4-[2-(4-methylphenyl)-2-adamantyl]-2-pyridinyl]carbazole.
Molecular Properties
| Compound Name | 2-[3-(3-methyl-2H-benzimidazol-1-yl)-5-phenylphenoxy]-9-[4-[2-(4-methylphenyl)-2-adamantyl]-2-pyridinyl]carbazole |
|---|---|
| PubChem CID | 162696349 |
| Molecular Formula | C54H48N4O |
| Molecular Weight | 769.00 g/mol |
| Exact Mass | 768.38 |
| IUPAC Name | 2-[3-(3-methyl-2H-benzimidazol-1-yl)-5-phenylphenoxy]-9-[4-[2-(4-methylphenyl)-2-adamantyl]-2-pyridinyl]carbazole |
| SMILES | Cc1ccc(C2(c3ccnc(-n4c5ccccc5c5ccc(Oc6cc(-c7ccccc7)cc(N7CN(C)c8ccccc87)c6)cc54)c3)C3CC4CC(C3)CC2C4)cc1 |
| InChI | InChI=1S/C54H48N4O/c1-35-16-18-40(19-17-35)54(42-25-36-24-37(27-42)28-43(54)26-36)41-22-23-55-53(31-41)58-49-13-7-6-12-47(49)48-21-20-45(33-52(48)58)59-46-30-39(38-10-4-3-5-11-38)29-44(32-46)57-34-56(2)50-14-8-9-15-51(50)57/h3-23,29-33,36-37,42-43H,24-28,34H2,1-2H3 |
| InChIKey | HLALNOOCZDOLPV-UHFFFAOYSA-N |
| XLogP | 13.23 |
| TPSA | 33.53 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 59 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 769.00 |
| LogP ≤ 5 | 13.23 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162696349 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.